Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2018

01-02-2018 | Original article

Night-time blood pressure and pulse wave velocity in dialysis patients

Authors: Xiurong Li, Qingbo Jiang, Wenhui Wu, Xianlin Xu, Liying Miao, Lina Jin, Lina Xue, Tian Huang, Jia Di, Jinfeng Liu, Xiaozhou He

Published in: Clinical and Experimental Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Ambulatory blood pressure (ABP) monitoring and carotid-femoral pulse wave velocity (cfPWV) provide important cardiovascular risk information for dialysis patients. This study aims to evaluate the risk factors of cfPWV and the associations between ambulatory blood pressure, especially night-time blood pressure and cfPWV.

Methods

We conducted a cross-sectional study in patients on maintenance hemodialysis. ABP and cfPWV were measured on a midweek interdialytic day. Associations were determined using Pearson’s correlation analysis and multiple stepwise regression model.

Results

Systolic BPs and pulse pressures, but not diastolic BPs, were significantly and positively associated with cfPWV. In a stepwise regression model, age, diabetes mellitus and all-period systolic BP were independently associated with cfPWV. When day-time and night-time BPs were included in the analysis, respectively, only night-time systolic BP and age remained as independently associated with cfPWV.

Conclusion

Ambulatory BPs are potent associates of cfPWV and night-time systolic BP, rather than day-time BPs, is an independently predictor of cfPWV. Our results support the view that controlling of nocturnal hypertension provides a unique cardiovascular protection effect.
Literature
4.
go back to reference Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients. J Hum Hypertens. 2002;16(8):585–9. doi:10.1038/sj.jhh.1001449.CrossRefPubMed Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients. J Hum Hypertens. 2002;16(8):585–9. doi:10.​1038/​sj.​jhh.​1001449.CrossRefPubMed
5.
go back to reference Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68(3):1294–302. doi:10.1111/j.1523-1755.2005.00527.x.CrossRefPubMed Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68(3):1294–302. doi:10.​1111/​j.​1523-1755.​2005.​00527.​x.CrossRefPubMed
7.
go back to reference Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735–8.CrossRefPubMed Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc’h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735–8.CrossRefPubMed
9.
go back to reference Lindroos AS, Johansson JK, Puukka PJ, Kantola I, Salomaa V, Juhanoja EP, et al. The association between home vs. ambulatory night-time blood pressure and end-organ damage in the general population. J Hypertens. 2016;34(9):1730–7. doi:10.1097/HJH.0000000000000995.CrossRefPubMed Lindroos AS, Johansson JK, Puukka PJ, Kantola I, Salomaa V, Juhanoja EP, et al. The association between home vs. ambulatory night-time blood pressure and end-organ damage in the general population. J Hypertens. 2016;34(9):1730–7. doi:10.​1097/​HJH.​0000000000000995​.CrossRefPubMed
10.
go back to reference Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–8. doi:10.1097/HJH.0b013e32834fa8b0.CrossRefPubMed Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–8. doi:10.​1097/​HJH.​0b013e32834fa8b0​.CrossRefPubMed
11.
go back to reference Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–9.CrossRefPubMed Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–9.CrossRefPubMed
14.
go back to reference Nurnberger J, Dammer S, Opazo Saez A, Philipp T, Schafers RF. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens. 2003;17(3):153–8. doi:10.1038/sj.jhh.1001526.CrossRefPubMed Nurnberger J, Dammer S, Opazo Saez A, Philipp T, Schafers RF. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens. 2003;17(3):153–8. doi:10.​1038/​sj.​jhh.​1001526.CrossRefPubMed
15.
go back to reference Kim EJ, Park CG, Park JS, Suh SY, Choi CU, Kim JW, et al. Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: invasive study. J Hum Hypertens. 2007;21(2):141–8. doi:10.1038/sj.jhh.1002120.CrossRefPubMed Kim EJ, Park CG, Park JS, Suh SY, Choi CU, Kim JW, et al. Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: invasive study. J Hum Hypertens. 2007;21(2):141–8. doi:10.​1038/​sj.​jhh.​1002120.CrossRefPubMed
21.
go back to reference Wang C, Zhang J, Liu X, Li CC, Ye ZC, Peng H, et al. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens. 2013;15(1):48–54. doi:10.1111/jch.12021.CrossRef Wang C, Zhang J, Liu X, Li CC, Ye ZC, Peng H, et al. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens. 2013;15(1):48–54. doi:10.​1111/​jch.​12021.CrossRef
Metadata
Title
Night-time blood pressure and pulse wave velocity in dialysis patients
Authors
Xiurong Li
Qingbo Jiang
Wenhui Wu
Xianlin Xu
Liying Miao
Lina Jin
Lina Xue
Tian Huang
Jia Di
Jinfeng Liu
Xiaozhou He
Publication date
01-02-2018
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1464-z

Other articles of this Issue 1/2018

Clinical and Experimental Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine